Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:oxycodone
gptkb:naloxone |
| gptkbp:approvedBy |
gptkb:Australia
gptkb:Europe |
| gptkbp:ATCCode |
N02AA55
|
| gptkbp:broadcastOn |
prescription only
|
| gptkbp:contraindication |
acute asthma
severe respiratory depression |
| gptkbp:form |
prolonged-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Targin
|
| gptkbp:legalStatus |
controlled substance
|
| gptkbp:marketedAs |
gptkb:Mundipharma
|
| gptkbp:mechanismOfAction |
opioid receptor agonist and antagonist combination
|
| gptkbp:prevention |
opioid-induced constipation
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting constipation dizziness headache drowsiness |
| gptkbp:usedFor |
pain management
|
| gptkbp:bfsParent |
gptkb:Oxycodone
|
| gptkbp:bfsLayer |
7
|